Research Portfolio

Funding Opportunities

Join our Mailing List
Join our mailing list to be notified of new funding opportunities.

Your Email

To receive information about funding opportunities, events, and program updates.



Shyam Krishnan, Ph.D.

University of California, San Francisco # of Grants: 2

Grants

Chemical synthesis of communesin B, a novel antineoplastic 2005 (Cycle 14) $74,403
General Biomedical Science Postdoctoral Fellowship Awards

Reversible Covalent Kinase Inhibitors to Combat Metastasis 2010 (Cycle 19) $135,000
Cancer Postdoctoral Fellowship Awards
Publications

Preparation of 3,3 disubsituted oxindoles by addition of malonates to 3 halo 3 oxindoles
Periodical: Index Medicus:
Authors: Syam Krishnan ART
Yr: Vol: Nbr: Abs: Pg:

Preparation of 3,3 disubsituted oxindoles by addition of malonates to 3 halo 3 oxindoles
Periodical: Index Medicus:
Authors: Syam Krishnan ART
Yr: Vol: Nbr: Abs: Pg:

Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles
Periodical: Nature Chemical Biology Index Medicus:
Authors: Serafimova IM, Pufall MA, Krishnan S, et al ART
Yr: 2012 Vol: 8 Nbr: Abs: Pg: 471-476

Electrophilic Fragment-Based Design of Reversible Covalent Kinase Inhibitors
Periodical: Journal of the American Chemistry Society Index Medicus:
Authors: Miller RM, Paavilainen VO, Krishnan S, Serafimova, IM, Taunton J ART
Yr: 2013 Vol: 8 Nbr: Abs: Pg: 471-476

Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles
Periodical: Nature Chemical Biology Index Medicus:
Authors: Serafimova IM, Pufall MA, Krishnan S, et al ART
Yr: 2012 Vol: 8 Nbr: Abs: Pg: 471-476

Electrophilic Fragment-Based Design of Reversible Covalent Kinase Inhibitors
Periodical: Journal of the American Chemistry Society Index Medicus:
Authors: Miller RM, Paavilainen VO, Krishnan S, Serafimova, IM, Taunton J ART
Yr: 2013 Vol: 8 Nbr: Abs: Pg: 471-476